eCCF

federal-form.jpgEarlier this year, the Department of Health and Human Services (HHS) revised the Mandatory Guidelines for Federal Workplace Drug Testing Programs. The HHS guideline revisions will lead to the following changes:

  • Expanded Federal urine workplace drug testing to include four Schedule II drugs: hydrocodone, hydromorphone, oxycodone, and oxymorphone
  • Removed MDEA for confirmatory testing
  • Raised the lower pH cutoff from 3 to 4 to identify an adulterated specimen
  • Allowed a Medical Review Officer (MRO) to recommend the collection of an oral fluid specimen in certain situations, as permitted by agency policy

This week, the Office of Management and Budget (OMB) approved the revised Federal Custody and Control Form (CCF). This approval essentially links the forthcoming testing changes to the required paperwork that will accompany the testing specimens. HHS published a Q&A document to help clarify a number of the changes.

While the impact of these revised regulations is somewhat complex, here are a few key insights that you should be aware of at this time:

1. These changes only apply to Federal employee testing. If your company performs oral fluid, hair, instant, or non-DOT urine drug testing, these changes do not apply to your program.

2. At this time, you should not order new paper CCF forms. The new Federal form was approved earlier this week—on August 8, 2017—as such, the printing of new forms has not yet begun. The Federal forms you have on hand today are still valid and can be used without issue for another 10 months—until June 30, 2018.

**Update** On Tuesday, August 15, 2017, the Department of Transportation published a notice in response to the HHS release from August 8, 2017. In this notice, they state that because the DOT’s final rule on synthetic opiates has yet to be issued, “…employers and their service agents are to continue using the ‘old’ CCF until further notice from DOT’s Office of Drug and Alcohol Policy and Compliance.”

3. The anticipated go-live date for the testing changes detailed in the bullet points above is October 1, 2017. This week’s announcement only pertains to Federal CCF forms, and was essentially published to give laboratories and other service providers the ability to cease production of the legacy form and to transition production to the new form.

4. There has never been a better time to switch to eCCF. You have better things to do than keeping tabs on changing form and panel regulations, ensuring you’re using the correct form at the proper time, and dealing with the expense and hassles of shipping and storing all of this paperwork. Our electronic CCF process helps bear the regulatory and administrative burden for you— the new, online form is scheduled to go live in our system on October 1. There’s no cost to use it, it’s available today for all specimen types and testing reasons, and it’s simple to use. In the time it’s taken you to read this article, you could have signed up and got started.

As your partner in drug testing and workplace safety, we are aware of the changes and are working diligently on your behalf to ready our laboratories, systems, and personnel. We are committed helping create a smooth and seamless transition as we collectively adapt to the regulatory obligations to which we’re bound.

As we do all of this, you should do three simple things:

  • Continue testing as usual. The effort at this point falls on the laboratory, not on you or your drug testing program. You do not need new forms at this time
  • Join the thousands of customers of all sizes and in all industries who have moved away from paper-based drug testing documentation and who are now processing millions of electronic CCFs each year

For more information about drug testing, visit our website or contact us online.

See the eCCF Difference for Yourself

by Steve Beller on April 7, 2017

If a picture is worth a thousand words, imagine how much a 3-minute video can say about electronic custody and control forms (eCCFs). Since we launched eCCF in January, clients have been asking for more information about how it works and the advantages it can bring to their regulated and non-regulated drug testing programs. The eCCF Difference video provides an informative, easy-to-understand look into the benefits employers and Third Party Administrators (TPAs) can realize by adopting eCCF. These benefits include:

  • Fewer data entry and legibility issues compared with handwritten paper forms
  • Reduced collection site flaws
  • Less paperwork to manage
  • Accurate data from the Federal eCCF immediately replaces outdated account and Medical Review Officer (MRO) demographics
  • Streamlined delivery of eCCF copies to employers and MROs
  • Improved overall efficiency

eCCF can be used for the majority of our drug testing products including: DOT urine, non-DOT urine, Express Results™ Online, oral fluid, and hair.

For more information on drug testing, visit our website or contact us online.

By the Numbers: Going Green with eCCF

March 1, 2017By the Numbers

Our By the Numbers blog series takes a closer look at the numbers, facts, data, and outputs that impact workplace drug testing programs. In this post, we examine the environmental impact of moving from paper-based custody and control forms (CCF) to electronic custody and control forms (eCCF). Paper-based CCFs have been a mainstay of the drug testing […]

Read the full article →

Online Solutions New Website Content

February 7, 2017Drug Testing

One of the most challenging problems we face as marketers is keeping our materials fresh, relevant, and engaging. With that in mind, we are pleased to announce the launch of our new and improved Quest Diagnostics Online Solutions web content. What’s new? We’ve audited and updated all of our online solutions web pages. You can […]

Read the full article →

Ask the Experts: Getting Started with eCCF

December 21, 2016Webinars

Our recent Gain the eCCF Advantage webinar was well received by many in the drug testing industry. Throughout the presentation, our audience posed a number of questions. Answers to the most frequent and important inquiries from the webinar are provided below as part of our ongoing effort to simplify the complexities of electronic Custody and […]

Read the full article →

Gain the eCCF Advantage Webinar Highlights

November 18, 2016Webinars

In Tuesday’s webinar, experts from Quest Diagnostics shared the benefits of using electronic custody and control forms (eCCF) in federally-regulated drug testing. Charlie Sullivan, Director of Collection Services, and Barbara Rowland, Director of Laboratory Operations, discussed the due diligence it took for Quest to gain HHS National Laboratory Certification Program (NLCP) approval and the impacts […]

Read the full article →

Gain the eCCF Advantage Webinar

November 4, 2016Webinars

It’s not too late to get the inside scoop on what you need to know to easily integrate eCCF into your drug testing program by attending our upcoming webinar called “Gain the eCCF Advantage.” Join us on Tuesday, November 15 at 1 p.m. CT as Quest Diagnostics drug testing experts, Charlie Sullivan, Director of Collection […]

Read the full article →

Webinar: Gain the eCCF Advantage

October 13, 2016Webinars

With more than 5.8 million federally-regulated urine drug tests conducted in 2015 alone, electronic custody and control forms (eCCF) represents a tremendous opportunity for companies to improve efficiencies to save time on their drug testing programs. While non-regulated eCCFs have been available for several years, Quest Diagnostics will launch eCCF for federally-regulated testing beginning in […]

Read the full article →

Important Changes With eCCF

October 10, 2016Urine testing

The content below highlights a number of the changes you should expect as you prepare to make the transition to electronic custody and control forms, or eCCF, for Federal drug testing from Quest Diagnostics. One of the biggest changes is the use of the Specimen ID as the single, identifying number for all drug testing […]

Read the full article →

Speed up Testing with eCCF

September 27, 2016eCCF

As we reported, Quest Diagnostics was approved on August 5, 2016, by the U.S. Department of Health and Human Services (HHS) National Laboratory Certification Program (NLCP) to perform federally-regulated drug testing using electronic Custody and Control Forms (eCCF). Since our announcement, we have been diligently working to complete the final last steps necessary to allow […]

Read the full article →